Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, we identified people who were prescribed a GLP-1 RA between January 01, 2018 and December 31, 2023
Tirzepatide is a dual GIP/GLP-1 receptor agonist (the active ingredient in Zepbound and Mounjaro)
Women with lean PCOS should use caution with Ozempic In addition, while the majority of women with PCOS have a higher-than-normal BMI, 1 in 5 women with PCOS do not
Yes, other classes of medications like SGLT2 inhibitors or metformin can be discussed with your healthcare provider, especially if gastroparesis is a concern
On a U-100 insulin syringe, 1 mL is 100 units, so 0.5 mL is the 50-unit mark and 0.25 mL is 25 units
After this period of time, you will start Zepbound at a low dose (generally 2.4 mg)